News & Perspective

Dec 11, 2015

Dec 11, 2015
Lab vials and syringes

GOF risk-benefit analysis unveiled ahead of NSABB debate

The analysis is a key part of a federal review of controversial studies on H5N1 and other pathogens.

Nov 12, 2015

Nov 12, 2015
Riyadh map

Saudi Arabia notes MERS case, upcoming meeting

The lastest patient, a foreign man in Riyadh, contracted the disease in a healthcare setting.

Nov 05, 2015

Nov 05, 2015
Child on nebulizer

New approach for attenuated RSV vaccine shows early promise

The candidate vaccine, given as nose drops, produced a strong immune response.

Oct 02, 2015

Oct 02, 2015
Culturing cells in petri dish

Work continues on policies for 'gain of function' research

The NSABB plans to release final recommendations in spring 2016.

Sep 23, 2015

Sep 23, 2015
Ebola hand washing

Ebola total grows by 2 with new cases in Guinea

Sierra Leone reports no cases after having 5 last week, and new funds for drugs and vaccines are announced.

Aug 19, 2015

Aug 19, 2015
IV drip

Riyadh MERS total grows; team reports promising vaccine results

Three new cases are noted, and an NIH study shows promising vaccine results in animals.

Jun 17, 2015

Jun 17, 2015
Ebola checkpoint

Ebola cases dip slightly, but hot spots persist

As cases drop slightly, vaccine trials suffer from lack of patients. Also, the NIH announces a trial involving survivors.

Apr 02, 2015

Apr 02, 2015
Ebola response training

Reports shed light on Ebola challenges for hospitals

Even hospitals that had done preparedness drills faced challenges, and the threat consumed a lot of resources.

Apr 01, 2015

Apr 01, 2015
Syringe and vials

Phase 1 trials of Ebola vaccine show good immune responses

The first two phase 1 trials of VSV-EBOV vaccine show good immune responses.

Mar 31, 2015

Mar 31, 2015
Lab worker with test tubes

BioCryst gets HHS contract for Ebola drug development

Funding will be used to continue trials of BCX4430 and prepare for its large-scale manufacture.

Pages

by Topic

by country

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»